Ticlopidine Hydrochloride contains not less than 99.0% and not more than 101.0% of C14H15Cl2NS, calculated on the anhydrous substance.

共有 1 個藥物證書使用此成份

梯可匹定鹽酸鹽
Ticlopidine Hydrochloride

• 申請商: 新雙隆生技股份有限公司
• 適應症: 血小板凝集抑制劑
• 發證日期: 2023-07-17